PATENT CLAIM ANALYSIS

Application Number: 16192752
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "184100"]

Abstract:
The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.

Claim (Index 15):
The method of  claim 14 , wherein the second cells are of a human gut commensul strain and/or a human gut probiotic strain.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 98.0
- Lexical Diversity: 1.67857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16041595', '16028311', '15820296', '15160405', '16192746']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7540641819161139
- 35 USC 102 Novelty (BERT): 0.5709517613494594
- Combined Prediction Score: 0.7357529398594485
- Mean Citation Score: 393.647904
- Max Citation Score: 463.46164000000016
- Similarity Product: 333.49634322156675

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test